Reduction in disease progression by inhibition of transforming growth factor α-CCL2 signaling in experimental posttraumatic osteoarthritis.

Saved in:
Bibliographic Details
Title: Reduction in disease progression by inhibition of transforming growth factor α-CCL2 signaling in experimental posttraumatic osteoarthritis.
Authors: Appleton CT; Western University Schulich School of Medicine and Dentistry, London, Ontario, Canada., Usmani SE; Western University Schulich School of Medicine and Dentistry, London, Ontario, Canada., Pest MA; Western University Schulich School of Medicine and Dentistry, London, Ontario, Canada., Pitelka V; Western University Schulich School of Medicine and Dentistry, London, Ontario, Canada., Mort JS; Shriners Hospitals for Children-Canada and McGill University, Montreal, Quebec, Canada., Beier F; Western University Schulich School of Medicine and Dentistry and Children's Health Research Institute, London, Ontario, Canada.
Source: Arthritis & rheumatology (Hoboken, N.J.) [Arthritis Rheumatol] 2015 Oct; Vol. 67 (10), pp. 2691-701.
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
Journal Info: Publisher: Wiley Country of Publication: United States NLM ID: 101623795 Publication Model: Print Cited Medium: Internet ISSN: 2326-5205 (Electronic) Linking ISSN: 23265191 NLM ISO Abbreviation: Arthritis Rheumatol Subsets: MEDLINE
Database: MEDLINE Ultimate
Be the first to leave a comment!
You must be logged in first